Direktorat Registrasi ObatValid

CANDESARTAN CILEXETIL

Claim this product
BPOM Number
GKL1502349710B1
Approved
13 April 2026
Expiry
22 March 2031
Form
Tablet

About This Registration

CANDESARTAN CILEXETIL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1502349710B1. Its current registration status is Valid, with the licence valid until 22 March 2031. The product is registered to BERNOFARM - INDONESIA. BPOM first approved this registration in April 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 10 STRIP @ 10 TABLET
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

CANDESARTAN CILEXETIL

Market Intelligence

Owner Portfolio
BERNOFARM - INDONESIA holds 482 BPOM registrations
Manufacturer Scale
BERNOFARM - INDONESIA produces 482 registered products
Registration Age
Registered for 3 months

FDA Cross-Reference

via openFDA
Generic Name
CANDESARTAN CILEXETIL
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

Products in the same class

ERDOMEX

-DKL1228206001A1
Valid
Approved: Jul 1, 2026KAPSUL
SIMEX PHARMACEUTICAL INDONESIA - INDONESIA
View product →

ZYPIN

-DKL2143501817A1
Valid
Approved: May 13, 2026TABLET SALUT SELAPUT
AMAROX PHARMA GLOBAL - INDONESIA
View product →

MAXLIS 5

-DKL2128209617A1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
SIMEX PHARMACEUTICAL INDONESIA - INDONESIA
View product →

STESOLID

-DPL7405505437A1
Valid
Approved: Feb 12, 2026SIRUP
ACTAVIS INDONESIA - INDONESIA
View product →

RESPIRA

-DKL1933545049A1
Valid
Approved: Jan 6, 2026INFUS
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →
1